Mandy Lawson

1.7k total citations
20 papers, 828 citations indexed

About

Mandy Lawson is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mandy Lawson has authored 20 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mandy Lawson's work include Estrogen and related hormone effects (5 papers), Receptor Mechanisms and Signaling (5 papers) and Adenosine and Purinergic Signaling (4 papers). Mandy Lawson is often cited by papers focused on Estrogen and related hormone effects (5 papers), Receptor Mechanisms and Signaling (5 papers) and Adenosine and Purinergic Signaling (4 papers). Mandy Lawson collaborates with scholars based in United Kingdom, United States and Japan. Mandy Lawson's co-authors include Martin Braddock, Christopher J. Morrow, Geoffrey L. Greene, Sharmeen Uddin, Sean W. Fanning, Wai Lin Wong, Kathryn E. Carlson, Zhiqiang Li, Joanne Wilson and Sarat Chandarlapaty and has published in prestigious journals such as Gastroenterology, Cancer Research and Oncogene.

In The Last Decade

Mandy Lawson

18 papers receiving 812 citations

Peers

Countries citing papers authored by Mandy Lawson

Since Specialization

Citations

This map shows the geographic impact of Mandy Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandy Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandy Lawson more than expected).

Fields of papers citing papers by Mandy Lawson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandy Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandy Lawson. The network helps show where Mandy Lawson may publish in the future.

Co-authorship network of co-authors of Mandy Lawson

This figure shows the co-authorship network connecting the top 25 collaborators of Mandy Lawson. A scholar is included among the top collaborators of Mandy Lawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandy Lawson. Mandy Lawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer 2024 ·npj Breast Cancer ·Zheqi Li, Fangyuan Chen, Li Chen, (unknown), (unknown), Fazal Hadi, Soleilmane Omarjee, Kamal Kishore, Joshua Kent, Joanna Kirkpatrick, Clive S. D’Santos, Mandy Lawson, Jason Gertz, Matthew J. Sikora, (unknown), Jason S. Carroll, Kornélia Polyák, Steffi Oesterreich, Adrian V. Lee	0
2	Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer 2022 ·Oncogene ·Alison Harrod, Chun‐Fui Lai, (unknown), (unknown), (unknown), Daniela Barsotti Santos, Balázs Győrffy, Rebecca C. Allsopp, Bradley Toghill, K. Balachandran, Mandy Lawson, Christopher J. Morrow, (unknown), Larissa S. Carnevalli, Pei Zhang, David S. Guttery, Jacqui Shaw, R. Charles Coombes, Lakjaya Buluwela, Simak Ali	17
3	Abstract 4379: Not all selective estrogen receptor degraders are equal - Preclinical comparison of AZD9833, AZD9496 and fulvestrant 2020 ·Cancer Research ·Mandy Lawson, (unknown), Michelle DuPont, Oona Delpuech, Dawn Trueman, Pei Zhang, (unknown), Sladjana Gagrica, Gareth Maglennon, Daniel Sutton, (unknown), Jonathan Cairns, (unknown), Teresa Klinowska, Christopher J. Morrow	3
4	Abstract 5674: Discovery of AZD9833, an oral small molecule selective degrader of the estrogen receptor (SERD) 2020 ·Cancer Research ·James S. Scott, Tom Moss, (unknown), (unknown), Christopher J. Morrow, Mandy Lawson, (unknown), Eric T. Gangl, Pablo Morentin Gutierrez, (unknown), Justin P.O. Lindemann, Andrew Sykes, David I. Fisher, Radosław Polański, Danielle Carroll, (unknown), Teresa Klinowska	11
5	Abstract 4369: Preclinical mechanistic PK/PD-efficacy modeling for AZD9833, a novel next generation oral SERD, to support dose selection during early clinical development 2020 ·Cancer Research ·Pablo Morentin Gutierrez, Christopher J. Morrow, (unknown), Mandy Lawson, Dawn Trueman, Eric T. Gangl, Joanne Wilson, Aaron Smith, James S. Scott, Teresa Klinowska	0
6	Tricyclic Indazoles—A Novel Class of Selective Estrogen Receptor Degrader Antagonists 2019 ·Journal of Medicinal Chemistry ·James S. Scott, Andrew Bailey, David Buttar, Rodrigo J. Carbajo, Jon Curwen, Paul R. J. Davey, Robert D. M. Davies, Sébastien L. Degorce, Craig S. Donald, Eric T. Gangl, Ryan Greenwood, Sam D. Groombridge, Tony Johnson, Scott G. Lamont, Mandy Lawson, (unknown), Christopher J. Morrow, Tom Moss, Jennifer H. Pink, Radosław Polański	26
7	Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor–positive Breast Cancer 2018 ·Molecular Cancer Therapeutics ·Chrysiis Michaloglou, Claire Crafter, Rasmus Siersbæk, Oona Delpuech, Jon Curwen, Larissa S. Carnevalli, Anna D. Staniszewska, Urszula M. Polanska, (unknown), Mandy Lawson, Igor Chernukhin, Robert McEwen, Jason S. Carroll, Sabina Cosulich	128
8	Abstract PD4-04: Combined inhibition of mTOR and CDK4/6 is required for optimal blockade of E2F function and long term growth inhibition in estrogen receptor positive breast cancer 2018 ·Cancer Research ·Elisabeth Oelmann, Chrysiis Michaloglou, Claire Crafter, Rasmus Siersbæk, Oona Delpuech, (unknown), Larissa S. Carnevalli, (unknown), Urszula M. Polanska, (unknown), Mandy Lawson, Igor Chernukhin, Robert McEwen, Joe Carroll, Sabina Cosulich	1
9	Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists 2016 ·Cancer Discovery ·Weiyi Toy, Hazel M. Weir, Pedram Razavi, Mandy Lawson, Anne U. Goeppert, Anne Marie Mazzola, Aaron Smith, Joanne Wilson, Christopher J. Morrow, Wai Lin Wong, Elisa de Stanchina, Kathryn E. Carlson, (unknown), Sharmeen Uddin, Zhiqiang Li, Sean W. Fanning, John A. Katzenellenbogen, Geoffrey L. Greene, José Baselga, Sarat Chandarlapaty	269
10	Discovery of AZD3199, An Inhaled Ultralong Acting β₂ Receptor Agonist with Rapid Onset of Action 2014 ·ACS Medicinal Chemistry Letters ·Michael J. Stocks, Lilian Alcaraz, Andrew Bailey, Roger V. Bonnert, Elaine Cadogan, (unknown), John Dixon, Stephen Connolly, Anthony R. Cook, (unknown), Alice W. Flaherty, Alexander C. Humphries, Anthony H. Ingall, (unknown), Mandy Lawson, (unknown), David Nicholls, Stuart W. Paine, Garry Pairaudeau, Alan Young	16
11	Abstract 3264: AZD8186: a potent selective inhibitor of PI3Kβ targeting PTEN-deficient tumours dependent on dysregulated PI3Kβ signalling. 2013 ·Cancer Research ·Urs J. Hancox, Sabina Cosulich, Hannah Dry, (unknown), (unknown), Bernard Barlaam, Martina Fitzek, Lara Ward, Marie Cumberbatch, Steve Powell, Rebecca Ellston, Mandy Lawson, Stephen R. Wedge, (unknown), Stephen Green, Simon T. Barry	2
12	Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action 2012 ·Pulmonary Pharmacology & Therapeutics ·D.J. Nicholls, Shawn Jordan, Elaine Cadogan, Mandy Lawson, Rupert P. Austin, Stuart W. Paine, Philip Gardiner, Roger V. Bonnert, Stephen Connolly, Alan Young	3
13	From libraries to candidate: The discovery of new ultra long-acting dibasic β2-adrenoceptor agonists 2011 ·Bioorganic & Medicinal Chemistry Letters ·Lilian Alcaraz, Andrew Bailey, Elaine Cadogan, Stephen Connolly, (unknown), (unknown), Nicholas D. Kindon, (unknown), Mandy Lawson, (unknown), Ian Dainty, David Nicholls, Stuart W. Paine, Garry Pairaudeau, Michael J. Stocks, (unknown), Alan Young	12
14	AZD3199: A Potent And Selective Beta2-Adrenergic Receptor Agonist With Rapid Onset Of Action 2011 ·Alan Young, David Nicholls, Stephen Connolly, Elaine Cadogan, Roger V. Bonnert, (unknown), Mandy Lawson, Michael J. Stocks, (unknown), Stuart W. Paine, Rupert P. Austin, P. Jane Mutch, Philip Gardiner	1
15	Agonist‐specific patterns of β₂‐adrenoceptor responses in human airway cells during prolonged exposure 2009 ·British Journal of Pharmacology ·Caroline Düringer, Gunilla Grundström, (unknown), Ian Dainty, Mandy Lawson, Solange H. Korn, (unknown), (unknown), Elisabet Wieslander, Karin Fredriksson, C. Magnus Sköld, Magnus Löfdahl, Claes‐Göran Löfdahl, David Nicholls, David S. Silberstein	20
16	Characterization of a selective and potent antagonist of human P2X₇receptors, AZ11645373 2006 ·British Journal of Pharmacology ·Leanne Stokes, Lin‐Hua Jiang, Lindsay B. Alcaraz, Julian Bent, Katherine Bowers, (unknown), Mark Furber, Michael Mortimore, Mandy Lawson, (unknown), Laurent Costet, Martin Braddock, Annmarie Surprenant	114
17	Novel P2X7 receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Lilian Alcaraz, Andrew Baxter, (unknown), Keith Bowers, Martin Braddock, (unknown), David K. Donald, Malbinder Fagura, Mark Furber, (unknown), Mandy Lawson, Michael Mortimore, (unknown), Nicola Roberts, Mark J. Robertson	52
18	Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Andrew Baxter, (unknown), Keith Bowers, Martin Braddock, (unknown), Malbinder Fagura, Mandy Lawson, Tom McInally, (unknown), Mark J. Robertson, Richard Weaver, Peter J. H. Webborn	105
19	Abating endosulfan from runoff using vegetative filter strips: the importance of plant species and flow rate 2003 ·Agriculture Ecosystems & Environment ·Wondi Mersie, C. A. Seybold, (unknown), Mandy Lawson	47
20	Presence of the purinergic receptor P2X7 in colonic macrophages and T cells from normal and IBD mucosa 2000 ·Gastroenterology ·(unknown), Keith Bowers, Shri Pathmakanthan, Mandy Lawson, (unknown), Chris J. Hawkey	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact